VectorB2B is proud to present a unique service for Portuguese companies – “Deconfinement 360°”

Companies are returning to work after an unusual Summer and manage into the COVID-19-era. Until the world finds a vaccine that is safe, effective, and readily distributed, companies worldwide have to face significant challenges. The goal is to rebuild for the longer term.

VectorB2B is providing a unique service to Portuguese companies. Our team will guarantee your company access to innovative techniques, serological tests (antibodies), and diagnostics for COVID19. We will help your company maintain a safe work environment for your employees, suppliers, and customers.

Contact us for more information.

More News

VectorB2B participa ativamente no Encontro Ciência 2024

Estamos a organizar a sessão científica intitulada “Como podem os CoLABs apoiar os desafios da Saúde Global?” https://lnkd.in/dnDVwafm Juntem-se a nós no próximo dia 4 de Julho, 11h30-13h30 Visitem-nos no nosso stand!

VectorB2B is now member of Europharm SMC

The European Pharmaceutical Association representing Small and Medium Sized Pharmaceutical Companies. Europharm’s mission is to support and defend the interests of SMEs, in order to enhance their competitiveness and entrepreneurship within the global framework of the pharmaceutical industry. Europharm SMC is a unique business network of pharmaceutical SMEs coming from all European countries who share this common goal. The […]

VectorB2B is member of Health Cluster Portugal!

O Health Cluster Portugal conta com um novo Associado / The Health Cluster Portugal has a new Member: VectorB2B – Drug Development https://lnkd.in/dBafiV6N hashtag#healthclusterportugal hashtag#healthportugal

© 2024 digital connection | All rights reserved | Privacy policy| Data Privacy Contact Form